
Health Plans Anticipate 14% Premium Hikes for 2027 Amid Rising Costs
Driven by inflation and the high cost of GLP-1 drugs, health insurers are projecting median premium increases of 14% heading into 2027.

Driven by inflation and the high cost of GLP-1 drugs, health insurers are projecting median premium increases of 14% heading into 2027.

Arnold Ventures provides context on 2026 Medicare Advantage availability, showing that 99% of seniors maintain access despite some rural market exits.

The 2026 Medicare Trustees Report projects Part A Trust Fund depletion by 2033. The Bipartisan Policy Center explains what this means for the future of the program.

KFF’s 2026 report highlights the state of Medicare Advantage, detailing plan choices, out-of-pocket caps, and the persistence of prior authorization requirements.

Medicare covers free preventive services that can help seniors beat the heat—from wellness visits to telehealth check-ins.

If your Medicare Advantage plan exits your county, you have options. Learn about Special Enrollment Periods and how to find new coverage.

Medicare telehealth rules remain expanded through 2026, allowing beneficiaries to access virtual care and behavioral health services from home.

Medicare has named 15 additional prescription drugs for price negotiations, building on the Inflation Reduction Act’s cost-cutting momentum.

Medicare Part D now caps annual out-of-pocket drug costs at $2,000. Here’s how the cap works and how the payment plan can help you save.
This website is privately owned and all information and advertisements are independent and are not associated with any state exchange or the federal marketplace. Additionally, this website is not associated with, sanctioned by or managed by the federal government, the Centers for Medicare & Medicaid or the Department of Health and Human Services.
